Hertraz Tablet (Trastuzumab) is a targeted therapy medicine that treats HER2-positive breast and gastric cancers. It blocks the growth of cancer cells that overexpress the HER2 protein. As a result, the treatment slows down cancer progression and improves survival rates. For additional information about cancer therapies, visit Mayo Clinic, WebMD, and Healthline.

Key Benefits & Uses

• Provides effective results against HER2-positive breast and gastric cancers

• Reduces the risk of recurrence while improving survival chances

• Works well as monotherapy and in combination with chemotherapy

• Strengthened by worldwide studies found on PubMed and supported by WHO

How to Use

You should take Hertraz Tablet only under medical supervision. Your oncologist determines the correct dosage and schedule depending on your health status. To read more about recommended dosages, check Drugs.com and the official FDA guidelines.

Important Safety Information

• Avoid use if you have serious heart conditions

• Schedule regular heart check-ups during the treatment

• Inform your doctor immediately if you are pregnant, planning pregnancy, or breastfeeding

• Do not skip prescribed doses and never self-medicate

Common Side Effects

Some patients may experience:

• Fever, chills, or weakness

• Headache, nausea, or diarrhea

• Lowered white blood cell count

• Rare but serious heart issues

If these effects become severe, contact your healthcare provider without delay. For more details, consult WebMD or Healthline.

Why Choose Hertraz Tablet (Trastuzumab)?

Hertraz remains a trusted and effective targeted therapy for HER2-positive cancers. It directly attacks HER2 receptors, which makes the treatment more precise than traditional chemotherapy. In addition, strong clinical studies and approvals from authorities like the FDA ensure its reliability. Therefore, Hertraz provides long-term benefits and greater confidence in cancer management.